[SARS-CoV-2 protease: an excellent target to develop drugs against COVID-19]

Med Sci (Paris). Jun-Jul 2020;36(6-7):555-558. doi: 10.1051/medsci/2020106. Epub 2020 Jun 19.
[Article in French]
No abstract available

Publication types

  • News

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Betacoronavirus / enzymology*
  • Betacoronavirus / physiology
  • COVID-19
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / prevention & control
  • HIV Protease Inhibitors / therapeutic use
  • Humans
  • Pandemics / prevention & control
  • Peptide Hydrolases / physiology
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / prevention & control
  • Protease Inhibitors / therapeutic use*
  • SARS-CoV-2
  • Virus Replication

Substances

  • Antiviral Agents
  • HIV Protease Inhibitors
  • Protease Inhibitors
  • Peptide Hydrolases